do-me/EUR-LEX huggingface dataset:
Statement of revenue and expenditure for the Executive Agency for Health and Consumers for the financial year 2008 — Amending Budget No 1
Date: 2009-03-31
Institutions: European Commission, Executive Agency for Health and Consumers
Subjects: EU office or agency, consumer, expenditure, financial year, public health, publication of accounts, revenue

31.3.2009

EN

Official Journal of the European Union

L 85/145

Statement of revenue and expenditure for the Executive Agency for Health and Consumers
for the financial year 2008 — Amending Budget No 1

(2009/284/EC)

L 85/146

EN

Official Journal of the European Union

31.3.2009

EAHC

Title
Chapter

1

1 0

REVENUE

Heading

Budget 2008

Amending budget
No 1

New amount

EUROPEAN COMMUNITY CONTRIBUTION

EUROPEAN COMMUNITY CONTRIBUTION

4 100 000

340 000

4 440 000

Title 1 — Total

4 100 000

340 000

4 440 000

2

2 0

PARTICIPATION OF THIRD COUNTRIES

PARTICIPATION OF EFTA COUNTRIES IN THE EXECUTIVE AGENCY

Title 2 — Total

93 500

93 500

93 500

93 500

GRAND TOTAL

4 193 500

340 000

4 533 500

31.3.2009

EN

Official Journal of the European Union

L 85/147

EAHC

Title
Chapter

Heading

Appropriations 2008

Amending budget
No 1

New amount

EXPENDITURE

1

1 1

1 2

1 3

1 4

2

2 0

2 1

2 2

2 3

2 4

2 5

3

3 1

3 2

3 3

EXPENSES FOR STAFF LINKED TO THE AGENCY

STAFF IN ACTIVE EMPLOYMENT

RECRUITMENT AND MUTATION EXPENSES AND PAYROLL SERVICE

SOCIAL INFRASTRUCTURE AND TRAINING

OTHER SERVICES

2 285 000

40 000

123 000

100 000

50 500

74 000

– 17 000

81 500

2 335 500

114 000

106 000

181 500

Title 1 — Total

2 548 000

189 000

2 737 000

CENTRAL SUPPORT COSTS

BUILDINGS AND ASSOCIATED COSTS

TELECOMMUNICATION AND COMPUTERS

MOVABLE PROPERTY AND ASSOCIATED COSTS

CURRENT ADMINISTRATIVE EXPENDITURE

POSTAL CHARGES

SUPPLEMENTARY SERVICES

Title 2 — Total

EXPENDITURE LINKED TO THE AGENCY OPERATIONS

MEETINGS AND MISSIONS

OPERATIONAL DATA PROCESSING

INFORMATION, PUBLICATION AND OTHER SERVICES

Title 3 — Total

565 000

135 000

15 000

25 000

8 000

100 000

848 000

494 000

143 500

160 000

797 500

42 000

73 000

35 000

1 000

– 10 000

141 000

28 500

61 500

– 80 000

10 000

607 000

208 000

50 000

26 000

8 000

90 000

989 000

522 500

205 000

80 000

807 500

GRAND TOTAL

4 193 500

340 000

4 533 500

L 85/148

EN

Official Journal of the European Union

31.3.2009

EAHC

Establishment plan

Function group and grade

Permanent posts

Temporary posts

2006

2007

2008

2006

2007

2008

AD16

AD15

AD14

AD13

AD12

AD11

AD10

AD9

AD8

AD7

AD6

AD5

Subtotal AD

AST11

AST10

AST9

AST8

AST7

AST6

AST5

AST4

AST3

AST2

AST1

Subtotal AST

Total

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

1

—

—

1

—

—

2

—

—

1

5

—

—

—

—

1

—

3

—

—

—

—

4

9

—

—

1

—

—

1

—

2

1

1

—

3

9

—

—

—

—

1

—

3

—

—

—

—

4

12
Case F-30/09: Action brought on 31 March 2009 — Chaouch v Commission
Date: 2009-03-31
Institutions: Civil Service Tribunal
Subjects: European Central Bank, European Commission, action for annulment (EU), damages, fixing of prices








C_2009129EN.01002103.xml










6.6.2009   


EN


Official Journal of the European Union


C 129/21





Action brought on 31 March 2009 — Chaouch v Commission
(Case F-30/09)
2009/C 129/37
Language of the case: French

Parties


Applicant: Dhikra Chaouch (Oetrange, Luxembourg) (represented by: F. Moyse and A. Salerno, lawyers)

Defendant: Commission of the European Communities

Subject-matter and description of the proceedings

Annulment of the decision of the appointing authority not to grant the applicant the installation allowance.

Form of order sought







—


Find that there was an infringement of Article 5 of Annex VII to the Staff Regulations in relation to Article 20 and, consequently, annul the decisions of the appointing authority of 2 July 2008 and 8 December 2008;










—


Declare that the applicant has a right to the installation allowance laid down in Article 5(1) of Annex VII to the Staff Regulations plus default interest from the date at which the indemnity was due until the date of actual payment at the interest rate applied by the European Central Bank to its main refinancing operations during the period concerned plus two percentage points;










—


Order the Commission of the European Communities to pay the costs.
Prior notification of a concentration (Case COMP/M.5500 — General Motors/Delphi Steering Business) Text with EEA relevance
Date: 2009-03-31
Institutions: European Commission
Subjects: economic concentration, exchange of information, marketing, merger control, motor vehicle, spare part

C 75/36

EN

Official Journal of the European Union

31.3.2009

PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION
POLICY

COMMISSION

Prior notification of a concentration

(Case COMP/M.5500 — General Motors/Delphi Steering Business)

(Text with EEA relevance)

(2009/C 75/13)

1.
On 23 March 2009, the Commission received a notification of a proposed concentration pursuant to
Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking General Motors
Corporation (‘GM’, USA) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of
the global steering business (‘Delphi Steering Business’) of Delphi Corporation (USA) by way of purchase of
shares and assets.

2.

The business activities of the undertakings concerned are:

— for GM: manufacture and sale of motor vehicles,

— for Delphi Steering Business: manufacture and sale of steering products and half-shaft components for

automotive vehicles.

On preliminary examination, the Commission finds that the notified transaction could fall within the

3.
scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

The Commission invites interested third parties to submit their possible observations on the proposed

4.
operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication.
Observations can be sent to the Commission by fax (+32 22964301 or 2967244) or by post, under refer-
ence number COMP/M.5500 — General Motors/Delphi Steering Business, to the following address:

European Commission
Directorate-General for Competition
Merger Registry
J-70
1049 Brussels
BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1.
Corrigendum to Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 ( OJ L 324, 10.12.2007 )
Date: 2009-03-31
Institutions: Council of the European Union, European Parliament
Subjects: drug surveillance, market approval, medicinal product, pharmaceutical legislation, preparation for market, qualitative analysis

L 87/174

EN

Official Journal of the European Union

31.3.2009

CORRIGENDA

Corrigendum to Regulation (EC) No 1394/2007 of the European Parliament and of the Council of
13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and
Regulation (EC) No 726/2004

(Official Journal of the European Union L 324 of 10 December 2007)

On page 131, Article 28, Amendments to Directive 2001/83/EC, point 4:

for:

‘4.

in Article 6(1), the first subparagraph shall be replaced by the following:

“No medicinal product may be placed on the market of a Member State unless a marketing authorisation has been issued by
the competent authorities of that Member State in accordance with this Directive or an authorisation has been granted in
accordance with Regulation (EC) No 726/2004, read in conjunction with Regulation (EC) No 1394/2007.”’,

read:

‘4.

in Article 6(1), the first subparagraph shall be replaced by the following:

“No medicinal product may be placed on the market of a Member State unless a marketing authorisation has been issued by
the competent authorities of that Member State in accordance with this Directive or an authorisation has been granted in
accordance with Regulation (EC) No 726/2004, read in conjunction with Regulation (EC) No 1901/2006 of the European
Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use (*) and Regulation (EC)
No 1394/2007.

(*) OJ L 378, 27.12.2006, p. 1.”’